138 related articles for article (PubMed ID: 27034421)
1. What mechanisms of tau protein transport could be responsible for the inverted tau concentration gradient in degenerating axons?
Kuznetsov IA; Kuznetsov AV
Math Med Biol; 2017 Mar; 34(1):125-150. PubMed ID: 27034421
[TBL] [Abstract][Full Text] [Related]
2. What tau distribution maximizes fast axonal transport toward the axonal synapse?
Kuznetsov IA; Kuznetsov AV
Math Biosci; 2014 Jul; 253():19-24. PubMed ID: 24747683
[TBL] [Abstract][Full Text] [Related]
3. A comparison between the diffusion-reaction and slow axonal transport models for predicting tau distribution along an axon.
Kuznetsov IA; Kuznetsov AV
Math Med Biol; 2015 Sep; 32(3):263-83. PubMed ID: 24573186
[TBL] [Abstract][Full Text] [Related]
4. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease.
Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A
Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322
[TBL] [Abstract][Full Text] [Related]
5. Investigating sensitivity coefficients characterizing the response of a model of tau protein transport in an axon to model parameters.
Kuznetsov IA; Kuznetsov AV
Comput Methods Biomech Biomed Engin; 2019 Jan; 22(1):71-83. PubMed ID: 30580604
[TBL] [Abstract][Full Text] [Related]
6. Modeling tau transport in the axon initial segment.
Kuznetsov IA; Kuznetsov AV
Math Biosci; 2020 Nov; 329():108468. PubMed ID: 32920097
[TBL] [Abstract][Full Text] [Related]
7. Tau and axonopathy in neurodegenerative disorders.
Higuchi M; Lee VM; Trojanowski JQ
Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
[TBL] [Abstract][Full Text] [Related]
8. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
9. Why slow axonal transport is bidirectional - can axonal transport of tau protein rely only on motor-driven anterograde transport?
Kuznetsov IA; Kuznetsov AV
Comput Methods Biomech Biomed Engin; 2024 Apr; 27(5):620-631. PubMed ID: 37068039
[TBL] [Abstract][Full Text] [Related]
10. Can numerical modeling help understand the fate of tau protein in the axon terminal?
Kuznetsov IA; Kuznetsov AV
Comput Methods Biomech Biomed Engin; 2016; 19(2):115-25. PubMed ID: 25563412
[TBL] [Abstract][Full Text] [Related]
11. Tau and Axonal Transport Misregulation in Tauopathies.
Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
[TBL] [Abstract][Full Text] [Related]
12. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
Terwel D; Dewachter I; Van Leuven F
Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
[TBL] [Abstract][Full Text] [Related]
13. Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.
Ballatore C; Brunden KR; Huryn DM; Trojanowski JQ; Lee VM; Smith AB
J Med Chem; 2012 Nov; 55(21):8979-96. PubMed ID: 23020671
[TBL] [Abstract][Full Text] [Related]
14. A coupled model of fast axonal transport of organelles and slow axonal transport of tau protein.
Kuznetsov IA; Kuznetsov AV
Comput Methods Biomech Biomed Engin; 2015; 18(13):1485-94. PubMed ID: 24867161
[TBL] [Abstract][Full Text] [Related]
15. Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.
Mandelkow EM; Stamer K; Vogel R; Thies E; Mandelkow E
Neurobiol Aging; 2003 Dec; 24(8):1079-85. PubMed ID: 14643379
[TBL] [Abstract][Full Text] [Related]
16. Bidirectional, unlike unidirectional transport, allows transporting axonal cargos against their concentration gradient.
Kuznetsov IA; Kuznetsov AV
J Theor Biol; 2022 Aug; 546():111161. PubMed ID: 35569529
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.
Kanaan NM; Morfini GA; LaPointe NE; Pigino GF; Patterson KR; Song Y; Andreadis A; Fu Y; Brady ST; Binder LI
J Neurosci; 2011 Jul; 31(27):9858-68. PubMed ID: 21734277
[TBL] [Abstract][Full Text] [Related]
18. Lost after translation: missorting of Tau protein and consequences for Alzheimer disease.
Zempel H; Mandelkow E
Trends Neurosci; 2014 Dec; 37(12):721-32. PubMed ID: 25223701
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies.
Kovalevich J; Cornec AS; Yao Y; James M; Crowe A; Lee VM; Trojanowski JQ; Smith AB; Ballatore C; Brunden KR
J Pharmacol Exp Ther; 2016 May; 357(2):432-50. PubMed ID: 26980057
[TBL] [Abstract][Full Text] [Related]
20. Embryonic stem cell-based modeling of tau pathology in human neurons.
Mertens J; Stüber K; Poppe D; Doerr J; Ladewig J; Brüstle O; Koch P
Am J Pathol; 2013 May; 182(5):1769-79. PubMed ID: 23499461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
